Hall of Famer Pedro Martinez to Pitch in 24th Annual Abbot Financial Management Oldtime Baseball Game on Thursday, August 17.
Cambridge’s Summertime Celebration of Baseball to Benefit John Martin Fund and ALS Therapy Development Institute.
St. Peter’s Field, 65 Sherman St, Cambridge, MA 02138
Planning to attend the Oldtime Baseball game Thursday night? Do yourself a favor and avoid Sherman Street. Your best bet is to park at the back of the Fresh Pond Shopping Center and then walk 10-12 minutes through the Danehy Park athletic complex to Saint Peter’s Field. There will also be a shuttle bus at the shopping center near the movie theater. If you take the T, the nearest stop is Alewife Station on the Red Line. Also, get to the park early!
2017 Beneficiaries
John Martin Fund
John Martin is a longtime videographer at NESN who has been diagnosed with amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s Disease. He has been with NESN for 19 years, and has been a fixture behind the camera during Red Sox and Bruins telecasts. He was in St. Louis in 2004 when the Red Sox won their first World Series in 86 years, and in Vancouver in 2011 when the Bruins won their first Stanley Cup in 39 years.
Martin and his wife, Adrienne, are the parents of two girls. He also has been involved as a coach in Boston’s fabled South End Little League for 30 years. The John Martin Fund was established to make sure John and his family don’t lose precious time worrying about the financial restraints caused by his diagnosis. To that end, a throng of Martin’s friends in the Boston media, as well as many of his former players from the South End Little League, plan to be in attendance at this year’s Oldtime Baseball Game.
ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) is a non-profit biotech and the world’s foremost drug discovery center dedicated to finding a cure for ALS (Amyotrophic Lateral Sclerosis).
Located in the heart of Kendall Square, Cambridge, ALS TDI and its scientists actively discover and develop treatments for ALS. It employs over 30 full-time, industry-trained drug development experts, and has screened over 300 drugs since its inception in 1999. Rated a four-star charity by CharityNavigator.com, ALS TDI spends 87% of each dollar raised on research to find an effective treatment and cure for ALS. ALS TDI is internationally recognized as a leader in optimizing preclinical models of neurodegeneration for clinical translation, and partners with pharmaceutical companies and other biotechs around the world.